文献速递头颈部肿瘤放疗

单侧N3鼻咽癌患者对侧未受累颈上颈照射与全颈照射的比较

Upper-Neck Versus Whole-Neck Irradiation at the Contralateral Uninvolved Neck in Patients With Unilateral N3 Nasopharyngeal Carcinoma.
PubMed 文献 · Int J Radiat Oncol Biol Phys · 2022-12-31

回顾性分析2009至2015年291例接受调强放疗的单侧N3鼻咽癌患者,190例接受双侧全颈照射(WNI组),101例接受患侧全颈照射加对侧未受累颈上颈照射(UNI组)。两组5年区域无复发生存率相似(89.7% vs 92.7%,P=.29),总生存、无远处转移生存和局部无复发生存亦相似。

要点

  • 单侧N3鼻咽癌对侧未受累颈上颈照射与全颈照射的区域控制相似(5年区域无复发生存率89.7% vs 92.7%,P=.29)。
  • 对侧未受累颈仅2例复发(UNI组和WNI组各1例),23例复发位于既往受累颈区域。
  • 5年总生存(76.1% vs 80.4%,P=.40)、无远处转移生存(74.9% vs 79.2%,P=.44)和局部无复发生存(95.6% vs 94.7%,P=.64)组间相似。

核心结论

  • 单侧N3鼻咽癌患者对侧未受累颈上颈照射与标准全颈照射的区域控制和生存结局相当。
  • 作者认为该发现为未来鼻咽癌放疗指南提供了证据。

研究设计与样本

  • 回顾性分析2009至2015年291例接受调强放疗的单侧N3鼻咽癌患者。
  • 190例接受双侧全颈照射(WNI组),101例接受患侧全颈照射加对侧未受累颈上颈照射(UNI组)。
  • 采用Kaplan-Meier法估计生存率,log rank检验比较组间差异。

主要发现

  • 中位随访79.4个月(四分位距56.0-89.3)。
  • 25例出现区域淋巴结复发:UNI组10.9%(11/101)vs WNI组7.4%(14/190),P=.31。
  • 23例复发位于既往受累颈区域,仅2例在对侧未受累颈复发(UNI组和WNI组各1例)。
  • 5年区域无复发生存率UNI组89.7% vs WNI组92.7%,P=.29。
  • 5年总生存UNI组76.1% vs WNI组80.4%(P=.40);无远处转移生存74.9% vs 79.2%(P=.44);局部无复发生存95.6% vs 94.7%(P=.64)。

关键数值与推荐

  • 单侧N3疾病定义为>6 cm和/或低于环状软骨下缘。
  • 5年区域无复发生存率UNI组89.7% vs WNI组92.7%,P=.29。
  • 5年总生存UNI组76.1% vs WNI组80.4%,P=.40。
  • 5年无远处转移生存UNI组74.9% vs WNI组79.2%,P=.44。
  • 5年局部无复发生存UNI组95.6% vs WNI组94.7%,P=.64。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: Upper-neck irradiation (UNI) at the uninvolved neck has shown similar regional relapse-free survival as standard whole-neck irradiation (WNI) in patients with N0-1 nasopharyngeal carcinoma. However, whether UNI at the contralateral uninvolved neck is feasible in unilateral N3 disease, defined as >6 cm and/or below the caudal border of the cricoid cartilage, remains unclear. METHODS AND MATERIALS: Data for 291 patients with nasopharyngeal carcinoma with unilateral N3 disease who were treated with intensity modulated radiation therapy from 2009 to 2015 were retrospectively analyzed. Among them, 190 received bilateral WNI (WNI group); the remaining 101 received WNI at the involved neck and UNI at the contralateral uninvolved neck (UNI group). Survival rates were estimated using the Kaplan-Meier method, and differences between groups were compared using the log rank tests. RESULTS: The median follow-up was 79.4 months (interquartile range, 56.0-89.3). Twenty-five patients had regional lymph node relapses (UNI: 10.9%, 11/101 vs WNI: 7.4%, 14/190; P = .31). Of these, 23 patients relapsed within the previously involved neck regions, while only 2 patients had relapses in the contralateral uninvolved neck (1 each in the UNI and WNI groups). Five-year regional relapse-free survival rates were similar between groups (89.7% vs 92.7%, P = .29). Similar between-group findings were also observed for 5-year overall survival (76.1% vs 80.4%, P = .40), distant metastasis-free survival (74.9% vs 79.2%, P = .44), and local relapse-free survival (95.6% vs 94.7%, P = .64). Furthermore, oncologic outcomes in subgroup and multivariable analyses were similar between groups. CONCLUSIONS: Regional control and survival outcomes were comparable in UNI at the contralateral uninvolved neck and standard WNI in patients with nasopharyngeal carcinoma with unilateral N3 disease. Our findings provide evidence for future radiation therapy guidelines of nasopharyngeal carcinoma.

来源:Int J Radiat Oncol Biol Phys,查看原文。版权归原作者所有。

引用

  1. Huang CL, Qiu YY, Du XJ, et al. Upper-Neck Versus Whole-Neck Irradiation at the Contralateral Uninvolved Neck in Patients With Unilateral N3 Nasopharyngeal Carcinoma. Int J Radiat Oncol Biol Phys. 2022. PMID: 36596345. doi:10.1016/j.ijrobp.2022.12.041

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。